Trademark Overview
On Monday, March 30, 2026, a trademark application was filed for NEWLIMIT with the United States Patent and Trademark Office. The USPTO has given the NEWLIMIT trademark a serial number of 99733191. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 30, 2026. This trademark is owned by NewLimit Incorporated. The NEWLIMIT trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations for use in the diagnosis, prevention and treatment of central nervous system, cardio-vascular, metabolic, hepatic, nephrologic, orthopedic, muscular, immunologic and auto-immunologic, dermatologic, pulmonary, respiratory, oncologic, inflammatory, infectious, ophthalmologic, auditory, genetic, and aging-related and gerontologic diseases and disorders; biological preparations for use in the diagnosis, prevention and treatment of central nervous system, cardio-vascular, metabolic, hepatic, nephrologic, orthopedic, muscular, immunologic and auto-immunologic, dermatologic, pulmonary, respiratory, oncologic, inflammatory, infectious, ophthalmologic, auditory, genetic, and aging-related and gerontologic diseases and disorders; gene therapy products for use in the diagnosis, prevention and treatment of central nervous system, cardio-vascular, metabolic, hepatic, nephrologic, orthopedic, muscular, immunologic and auto-immunologic, dermatologic, pulmonary, respiratory...
Medical services; providing information in the fields of health and wellness
Scientific and medical research and development services; providing information about scientific and medical research; development of pharmaceutical and biological preparations for gene therapy